Logiscreen

Twist Bioscience Corp

$88.55
Market Cap 5.43B
ROE -17.5%
Gross Margin 51.6%
Debt/Equity 0.2
Current Ratio 2.7
Revenue QoQ 19.3%
EPS QoQ 0.1%
F-Score 3

About

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Exchange
NASDAQ
Sector
Healthcare
Industry
Diagnostics & Research

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-68.37
vs median 37.08
P/B
12.21
vs median 2.65
ROE
-0.17
vs median 0.09

Lower quality - review fundamentals carefully

Mid-cap company with growth potential

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics